Spots Global Cancer Trial Database for relapse b acute lymphoblastic leukemia
Every month we try and update this database with for relapse b acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic Leukemia | NCT04094766 | Refractory B Ac... Relapse B Acute... | Dual Specificit... | 14 Years - 60 Years | Second Affiliated Hospital of Xi'an Jiaotong University |